An Open-Label Study Evaluating the Bleeding Profile of Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) Administered as an Extended Regimen
Phase of Trial: Phase II
Latest Information Update: 14 May 2007
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors McNeil-PPC
- 14 May 2007 New trial record.
- 09 May 2007 Results have been published.